These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3257653)

  • 21. Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography.
    Wolkin A; Angrist B; Wolf A; Brodie J; Wolkin B; Jaeger J; Cancro R; Rotrosen J
    Psychopharmacology (Berl); 1987; 92(2):241-6. PubMed ID: 3110848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia.
    Hazlett EA; Buchsbaum MS; Kemether E; Bloom R; Platholi J; Brickman AM; Shihabuddin L; Tang C; Byne W
    Am J Psychiatry; 2004 Feb; 161(2):305-14. PubMed ID: 14754780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study.
    Soyka M; Koch W; Möller HJ; Rüther T; Tatsch K
    Eur Arch Psychiatry Clin Neurosci; 2005 Oct; 255(5):308-12. PubMed ID: 15834758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral glucose utilization in polysubstance abuse.
    Stapleton JM; Morgan MJ; Phillips RL; Wong DF; Yung BC; Shaya EK; Dannals RF; Liu X; Grayson RL; London ED
    Neuropsychopharmacology; 1995 Aug; 13(1):21-31. PubMed ID: 8526968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral glucose utilization is reduced in second test session.
    Stapleton JM; Morgan MJ; Liu X; Yung BC; Phillips RL; Wong DF; Shaya EK; Dannals RF; London ED
    J Cereb Blood Flow Metab; 1997 Jun; 17(6):704-12. PubMed ID: 9236727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia.
    Shioiri T; Kato T; Inubushi T; Murashita J; Takahashi S
    Psychiatry Res; 1994 Dec; 55(4):223-35. PubMed ID: 7701036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional brain imaging and aging in schizophrenia.
    Buchsbaum MS; Hazlett EA
    Schizophr Res; 1997 Oct; 27(2-3):129-41. PubMed ID: 9416643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional cerebral glucose metabolism in bulimia nervosa.
    Andreason PJ; Altemus M; Zametkin AJ; King AC; Lucinio J; Cohen RM
    Am J Psychiatry; 1992 Nov; 149(11):1506-13. PubMed ID: 1415817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography.
    Buchsbaum MS; Nuechterlein KH; Haier RJ; Wu J; Sicotte N; Hazlett E; Asarnow R; Potkin S; Guich S
    Br J Psychiatry; 1990 Feb; 156():216-27. PubMed ID: 2317626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates.
    Wiesel FA; Wik G; Sjögren I; Blomqvist G; Greitz T; Stone-Elander S
    Acta Psychiatr Scand; 1987 Dec; 76(6):628-41. PubMed ID: 3502060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia.
    Buchsbaum MS; Ingvar DH; Kessler R; Waters RN; Cappelletti J; van Kammen DP; King AC; Johnson JL; Manning RG; Flynn RW; Mann LS; Bunney WE; Sokoloff L
    Arch Gen Psychiatry; 1982 Mar; 39(3):251-9. PubMed ID: 6978119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypofrontality in schizophrenia as assessed by PET.
    Buchsbaum MS; Wu JC
    Am J Psychiatry; 1987 Jan; 144(1):122-3. PubMed ID: 2879481
    [No Abstract]   [Full Text] [Related]  

  • 33. Positron emission tomography study of phencyclidine users as a possible drug model of schizophrenia.
    Wu JC; Buchsbaum MS; Bunney WE
    Yakubutsu Seishin Kodo; 1991 Feb; 11(1):47-8. PubMed ID: 1882590
    [No Abstract]   [Full Text] [Related]  

  • 34. Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia.
    Schroder J; Buchsbaum MS; Siegel BV; Geider FJ; Lohr J; Tang C; Wu J; Potkin SG
    Schizophr Res; 1996 Mar; 19(1):41-53. PubMed ID: 9147495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [No hypofrontality in schizophrenia demonstrated by positron emission tomography].
    Biver F; Delvenne V; Goldman S; Luxen A; De Maertelaer V; Lotstra F; Mendlewicz J
    Acta Psychiatr Belg; 1992; 92(5):261-78. PubMed ID: 1345405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia.
    Buchsbaum MS; Hazlett EA
    Schizophr Bull; 1998; 24(3):343-64. PubMed ID: 9718628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positron emission tomography in schizophrenic patients with and without neuroleptic medication.
    DeLisi LE; Holcomb HH; Cohen RM; Pickar D; Carpenter W; Morihisa JM; King AC; Kessler R; Buchsbaum MS
    J Cereb Blood Flow Metab; 1985 Jun; 5(2):201-6. PubMed ID: 2859295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frontal lobe impairment in schizophrenia: relationship to intellectual functioning.
    Crawford JR; Obonsawin MC; Bremner M
    Psychol Med; 1993 Aug; 23(3):787-90. PubMed ID: 8234585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.